Odey Asset Management Group LTD Bristol Myers Squibb CO Transaction History

Odey Asset Management Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $2.27 Million - $2.47 Million	-36,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $587,466 - $660,726	-9,900 Reduced 21.24%	36,700 $2.32 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $571,626 - $647,757	9,900 Added 26.98%	46,600 $2.89 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $499,641 - $553,668	8,700 Added 31.07%	36,700 $2.21 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $1.3 Million - $1.89 Million	28,000 New	28,000 $1.56 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.82 Million - $2.16 Million	-42,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $1.92 Million - $2.29 Million	42,500 New	42,500 $2.03 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Odey Asset Management Group LTD, based on Form 13F filings with the SEC.

Stay updated on Odey Asset Management Group LTD with notifications on news.